Table 2.
Tumor markers comparison between third and fourth surgeries.
| Ki-67 (%) | p53 | ACTH (IHQ) | |
|---|---|---|---|
| 2009 (after 3rd surgery) | <5% | No evidence | >50% |
| 2012 (after 4th surgery) | 10–15% | 25% | >50% |
Considerations: The Ki-67 and p53 immunohistochemical exams were made with primary monoclonal antibody performed with 1 : 50 dilution, according to the manufacturer's protocol.